Skip to main content

Table 1 Patient characteristics

From: Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function- a descriptive study

 

Normal kidney function (H)

CKD 3

CDK 4–5

Subjects

n = 19

n = 15

n = 13

Mean eGFR (mL/min/1.73m2)

88

47

20

Mean Age (years)

66

76

74

Sex ratio Female/Male

31%F (6F/13M)

13%F (2F/13M)

40% (5F/8M)

Smoking

32% (6/19)

20%(3/15)

8% (1/13)

Diabetes mellitus 2

21% (4/19)

40% (6/15)

69% (9/13)

STEMI

47% (9/19)

47% (7/15)

46% (6/13)

Non-STEMI

52% (10/19)

53% (8/15)

54% (7/13)

Angiography before sampling

89% (17/19)

85% (11/15)

77% (10/13)

PCI before sampling

68% (13/19)

40% (6/15)

69% (9/13)

Angiography after sampling

5% (1/19)

20% (3/15)

15% (2/13)

No angiography

5% (1/19)

7% (1/15)

8% (1/13)

PCI anytime

74% (14/19)

47% (7/15)

77% (10/13)

Hypertension

58% (11/19)

93% (14/15)

100% (13/13)

Chronic ischemic heart disease

26% (5/19)

47% (7/15)

69% (9/13)

Sample day

Mean 2.6

Mean 2.6

Mean 3.9

Medications:

 Acetylsalicylic acid

95% (18/19)

93% (14/15)

100% (13/13)

 P2Y12 receptor antagonists

100%

100%

100% (13/13)

 Clopidogrel

84% (16/19)

85% (11/15)

92%(12/13)

 Ticagelor

11% (2/19)

20% (3/15)

15%(2/13)

 Prasugrel

5% (1/19)

7% (1/15)

0% (0)

 LMWH

42% (8/19)

53% (8/15)

23% (3/13)

 Warfarin

0

0

8% (1/13)

 NOAK

0

0

0

 Statin

84% (16/19)

87% (13/15)

85% (11/13)

Laboratory parameters:

 Mean Platelet count 109/L

212 ± 57

188 ± 54

205 ± 83

 Mean Leucocyte count 109/L

9,0 ± 2.7

7.6 ± 1.3

11.5 ± 5.7

 Mean p-albumin (g/L)

35 ± 3

33 ± 3

30 ± 7

 Mean p-phosphate (mmol/L)

1.06 ± 0.16

1.05 ± 0.15

1.22 ± 0.37